№14 / 2023

6-7
PEDIATRIA
L.V. Osidak, O.I. Afanasyeva, E.G. Golovacheva, E.A. Smorodintseva, E.V. Obraztsova, E.S. Goncharova
Rimantadine in combination with sodium alginate as a means of treatment and prevention of acute respiratory viral infections of various etiologies in infants and preschool children
8-14
E.B. Belan, E.M. Nikiforova
Possibility of using a combination of interferon alpha-2b and a complex immunoglobulin drug for infectious diseases in children
15-18
O.A. Bashkina, D.F. Sergienko, T.M. Kuznetsova
Bronchiolitis in children: a series of clinical examples
19-24
N.V. Sturov, S.V. Popov, Z.A. Ivanov
Disturbances of the gut microbiota and their correction in patients with oxalate nephrolithiasis
25-31
D.I. Trukhan, V.A. Gudilin
Antibiotic-associated diarrhea: potentials for the use of synbiotics
32-39
Yu.P. Uspensky, Z.Kh. Gulunov
Upper gastrointestinal involvement in Crohn’s disease
40-43
N.A. Fadeeva, O.V. Knyazev, D.S. Bordin, K.A. Nikolskaya, S.M. Chudnykh, N.A. Dashkina, G.B. Artykova, E.I. Aliev
Features of the use of genetic engineering biological drugs in the treatment of patients with Crohn’s disease
44-48
S.V. Zakharov, A.Yu. Savchenko
Therapeutic horizons of indirect oral anticoagulants
50-56
O.D. Ostroumova, A.V. Dubinina, V.A. De, A.I. Kochetkov, V.B. Dashabylova, S.S. Eremina, M.V. Klepikova
On the issue of improving the safety of antithrombotic therapy in patients with atrial fibrillation and coronary heart disease receiving antithrombotic therapy
57-67
A.V. Dubinina, A.I. Kochetkov, A.E. Vorobyova, S.S. Eremina, K.B. Mirzaev, O.D. Ostroumova
Analysis of the structure of comorbidities and pharmacotherapy in patients with a combination of atrial fibrillation and coronary heart disease
68-77
E.V. Rebrova, E.V. Shikh, R.E. Kazakov, G.G. Melkonyan, N.P. Kulagina
Analysis of the frequency of CYP2C9, AGTR1, AGT, ACE, CYP11B2 gene Polymorphisms occurrence in patients with newly diagnosed 1–2 degree arterial hypertension
78-86
M.V. Leonova
Bempedoic acid – a new drug in lipid-lowering therapy
88-94
I.G. Trukhanova, S.Kh. Sadreeva, D.S. Zinatullina, I.A. Polyakov, D.P. Alcova
Clinical case of complete atrioventricular block complicated by Morgagni-Adams-Stokes syndrome at the prehospital stage
95-99
E.G. Bykova, O.V. Zakharova, N.A. Platonava
Endovascular treatment of a patient with chronic abdominal ischemia syndrome: a clinical case
100-105
E.Yu. Trushina, E.M. Kostina, V.A. Tipikin, E.A. Orlova
Modern ideas about the combination of bronchial asthma and chronic obstructive pulmonary disease
106-110
A.Y. Savchenko, G.V.Ramenskaya, V.G. Kukes, N.V. Shilova
Evaluation of the effectiveness of the new anti-tuberculosis drug thiozonide in patients with pulmonary tuberculosis with multi- and extensive drug resistance of Mycobacterium tuberculosis
112-117
N.L. Ryabkova, E.B. Moskvina
Dynamics of antibiotic resistance in the surgical departments of a multidisciplinary hospital using the example of the Republican Hospital n.a. V.A. Baranov
118-123
E.V. Panteleev, S.V. Matveev
Personalized approach to the rehabilitation of patients with degenerative dystrophic disk disease and clinical manifestations in the form of poor posture and pain syndrome
124-129
DERMATOLOGY / ALLERGOLOGY
E.M. Markelova, L.S. Kruglova, N.V. Gryazeva
Experience with the use of various forms of zinc pyrithione for seborrheic dermatitis
130-134
E.V. Svechnikova, Yu.V. Maksimova, G.B. Arutyunyan, N.O. Artemyeva, A.V. Devyatova, A.A. Sherf
Seborrheic dermatitis. association of MCM6 lactase gene polymorphism and seborrheic dermatitis by the example of a clinical case
135-137
Oncology
F.G. Ivanova, T.I. Nikolaeva, N.I. Spiridonova, L.N. Afanasyeva, P.V. Nikiforov, T.N. Zharnikova
Clinical experience with the use of combination drug therapy in the first line treatment of metastatic non-small cell lung cancer
138-142
G.G. Khakimova, A.A. Tryakin
Data in the treatment of colon cancer from real clinical practice in Tashkent, Uzbekistan
143-148
V.F. Semiglazov, P.V. Krivorotko, N.B. Bekkeldieva, A.V. Komyakhov, A.S. Emelyanov, A.O. Gorina
The role of cyclin-dependent kinase inhibitors in adjuvant therapy of breast cancer
149-152

Бионика Медиа